SCHEMBL16115155

SCHEMBL16115155

C[C@H](OC(N)=O)C(O)(Cc1ccccc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.41

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 11/20 0.41
PPARG P37231 2/20 0.41
PPARA Q07869 2/20 0.41
EPHX1 P07099 2/20 0.41
CETP P11597 4/20 0.41
KCNH2 Q12809 3/20 0.40
CACNA1F O60840 1/20 0.40
CACNA1D Q01668 1/20 0.40
CACNA1S Q13698 1/20 0.40
CACNA1C Q13936 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16115158 1.00 TACR1 (0.41) TACR1PPARGPPARAEPHX1CETP
SCHEMBL17500978 1.00 TACR1 (0.41) TACR1PPARGPPARAEPHX1CETP
SCHEMBL9049025 0.74 TRPA1 (0.51) PPARGPPARA
SCHEMBL16115249 0.71 CETP (0.45) TACR1CETP
SCHEMBL16115247 0.71 CETP (0.45) TACR1CETP
SCHEMBL16115157 0.71 PPARG (0.42) TACR1PPARGPPARAEPHX1CACNA1F
SCHEMBL16115159 0.71 PPARG (0.42) TACR1PPARGPPARAEPHX1CACNA1F
SCHEMBL16115248 0.69 CTSL (0.45) TACR1PPARGPPARACACNA1FCACNA1D
SCHEMBL1811694 0.68 SLC6A2 (0.50) EPHX1
SCHEMBL28914994 0.68 SLC6A2 (0.50) EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2978761-A1 NOVEL OXAZOLIDINONE DERIVATIVE AS CETP INHIBITOR, ITS PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Dong-A ST Co., Ltd. (KR) 2016-02-03 EP disclosed
WO-2014157994-A1 NOVEL OXAZOLIDINONE DERIVATIVE AS CETP INHIBITOR, ITS PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONG-A ST CO.,LTD (KR) 2014-10-02 WO disclosed